Delivery Order SPE2DB22D3401-SPE2DB25FT1RL

Award Date 1/17/25
Potential Completion Date 1/21/25
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a wholly owned subsidiary of Amerisourcebergen Corporation, to provide 4,563,927,592 units of the pharmaceutical product Teriparatide 600 mcg/2.4ml pen at a ceiling value of $2,299.97. The award, which has an ultimate completion date of March 12, 2024, is part of a larger indefinite delivery contract (IDC) valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,521.75 firm fixed-price delivery order is for the supply of TERIPARATIDE 620 MCG/2.48 ML 2.48ML, a specialty medication. This contract is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,943,582 units of the medication teriparatide 560mcg/2.24ml pen, with a ceiling value of $11,646.66 and a performance period through April 17, 2025. The contract is not set aside and was awarded on April 16, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $2,591.28, is for the delivery of teriparatide 600 mcg/2.4 ml pens. The contract is a firm fixed-price delivery order that was awarded without the use of a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This is a $1,964.22 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TERIPARATIDE 620 MCG/2.48 ML 2.48ML, and has an ultimate completion date of May 13, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug teriparatide 560 mcg/2.24 ml pen in a 2.24 ml quantity. The contract has a firm fixed price of $3,167.44 and a completion date of May 22, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award is a delivery order with a firm fixed price valued at $1,843.27. The award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of TERIPARATIDE 620 MCG/2.48 ML 2.48ML. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $2,591.28. The order is for 4,565,250,079 units of teriparatide 600 mcg/2.4 ml pen with a 2.4 ml capacity. The order has a firm fixed price and a completion date of July 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,566,077,851 units of the pharmaceutical product Teriparatide 600 mcg/2.4 ml pen (2.4 ml). The contract has a ceiling value of $4,241.15 and a period of performance through October 11, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML, a specialty medication, with a ceiling value of $1,403.14 and a performance period ending on January 17, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT1RL
    Delivery Order

This is a $21,502.81 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML, a specialized medication, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/21/25, 9:45 AM